首页> 外文期刊>BMC Infectious Diseases >Emerging human alveolar echinococcosis in Hungary (2003–2018): a retrospective case series analysis from a multi-centre study
【24h】

Emerging human alveolar echinococcosis in Hungary (2003–2018): a retrospective case series analysis from a multi-centre study

机译:匈牙利的新兴人肺炎术(2003-2018):多中心研究的回顾性案例序列分析

获取原文
获取外文期刊封面目录资料

摘要

Human alveolar echinococcosis (AE) caused by Echinococcus multilocularis is an underreported, often misdiagnosed and mistreated parasitic disease mainly due to its low incidence. The aim of this study was to describe the epidemiological and clinical characteristics of human AE patients in Hungary for the first time. Between 2003 and 2018, epidemiological and clinical data of suspected AE patients were collected retrospectively from health database management systems. This case series included a total of 16 AE patients. The mean age of patients was 53?years (range: 24–78?years). The sex ratio was 1:1. Four patients (25%) revealed no recurrence after radical surgery and adjuvant albendazole (ABZ) therapy. For five patients (31.3%) with unresectable lesions, a stabilization of lesions with ABZ treatment was achieved. In seven patients (43.8%), progression of AE was documented. The mean diagnostic delay was 33?months (range: 1–122?months). Three AE related deaths (fatality rate 18.8%) were recorded. AE is an emerging infectious disease in Hungary with a high fatality rate since based on our results, almost every fifth AE patient died in the study period. Differential diagnosis and appropriate surgical and medical therapy for AE is an urging challenge for clinicians in Hungary, as well as in some other European countries where E. multilocularis is prevalent.
机译:由海螺腺癌多联性引起的人肺炎血管病变(AE)是一种经常误报和虐待的寄生虫病,主要是由于其低发病率。本研究的目的是第一次描述匈牙利人AE患者的流行病学和临床特征。在2003年至2018年期间,回顾性来自卫生数据库管理系统的疑似AE患者的流行病学和临床数据。这种情况系列包括共16名AE患者。患者的平均年龄为53岁(范围:24-78岁)。性别比例为1:1。四名患者(25%)揭示了自由基手术和佐剂albendazole(ABZ)治疗后的复发。对于具有不可切除的病变的五名患者(31.3%),实现了对ABZ治疗的病变稳定。在7名患者中(43.8%),记录了AE的进展。平均诊断延迟为33?个月(范围:1-122个月)。记录了三个AE相关的死亡(死亡率为18.8%)。 AE是匈牙利的新兴传染病,因为基于我们的结果,几乎每次第五次患者都在研究期间死亡。对AE的鉴别诊断和适当的外科医疗和医疗治疗是匈牙利临床医生的挑战,以及其他一些欧洲国家。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号